These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11122406)

  • 1. Creutzfeldt-Jakob disease and haemophilia: prospect at the new millennium.
    Liras A
    Haemophilia; 2000 Nov; 6(6):716-8. PubMed ID: 11122406
    [No Abstract]   [Full Text] [Related]  

  • 2. Bleeding and clotting: new therapies and old issues revisited.
    Lee CA; Aledort LM
    Haemophilia; 2009 Mar; 15(2):592-6. PubMed ID: 19335754
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical implications of emerging pathogens in haemophilia: the variant Creutzfeldt-Jakob disease experience.
    Dolan G
    Haemophilia; 2006 Mar; 12 Suppl 1():16-20; discussion 26-8. PubMed ID: 16445813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creutzfeldt-Jakob disease.
    Clement P
    Haemophilia; 2000 Jul; 6 Suppl 1():68-78. PubMed ID: 10982271
    [No Abstract]   [Full Text] [Related]  

  • 5. Creutzfeldt-Jakob disease and haemophilia: assessment of risk.
    Evatt B
    Haemophilia; 2000 Jul; 6 Suppl 1():94-9. PubMed ID: 10982274
    [No Abstract]   [Full Text] [Related]  

  • 6. Batch recall of French plasma-derived products due to variant Creutzfeldt-Jakob disease risk: the psychological impact on haemophilic patients, changes in their therapeutic demands and behaviour and ethical considerations.
    Aouba A; Harroche A; Frenzel L; Torchet MF; Rothschild C; François I; Mamzer-Bruneel MF
    Haemophilia; 2015 Jan; 21(1):27-33. PubMed ID: 25545300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-transmitted prions and variant Creutzfeldt-Jakob disease.
    Grady GF; Vyas GN
    Biologicals; 2007 Apr; 35(2):75-7. PubMed ID: 17317213
    [No Abstract]   [Full Text] [Related]  

  • 8. [Creutzfeldt-Jakob disease and transfusion].
    Saura C
    Ann Biol Clin (Paris); 2001 Oct; 59 Spec No():23-4. PubMed ID: 11675288
    [No Abstract]   [Full Text] [Related]  

  • 9. New-variant Creutzfeldt-Jakob disease and treatment of haemophilia. Executive Committee of the UKHCDO. United Kingdom Haemophilia Centre Directors' Organisation.
    Ludlam CA
    Lancet; 1997 Dec; 350(9092):1704. PubMed ID: 9400534
    [No Abstract]   [Full Text] [Related]  

  • 10. Variant Creutzfeldt-Jakob disease and prions in the blood supply.
    Rohwer RG; Drohan W
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):84, 87, 131. PubMed ID: 16163166
    [No Abstract]   [Full Text] [Related]  

  • 11. Creutzfeldt-Jakob disease.
    Oney D
    Pulse; 1999; 36(2):22. PubMed ID: 10614475
    [No Abstract]   [Full Text] [Related]  

  • 12. Panel Discussion. Millennium Festival of Medicine--Transfusion 2020--18 October 2000.
    Fogden M; Whitehorn K; Starr D; Persaud R; Hannaford R; Barbara J; Love E; Robinson A; Ferguson E; Turner G; Wallington T; Klein H; Franklin I; Fry R
    Transfus Med; 2001 Apr; 11(2):136-45. PubMed ID: 11583001
    [No Abstract]   [Full Text] [Related]  

  • 13. [BSE, prions, vCJD and (not only) homologous transfusion].
    Köhler M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):43-7. PubMed ID: 12522730
    [No Abstract]   [Full Text] [Related]  

  • 14. New-variant Creutzfeldt-Jakob disease and treatment of haemophilia.
    Baxter T; Black D; Birks D
    Lancet; 1998 Feb; 351(9102):600-1. PubMed ID: 9492811
    [No Abstract]   [Full Text] [Related]  

  • 15. Second Workshop of the European Paediatric Network for Haemophilia Management, 17-19 September 1998 in Vitznau/Switzerland.
    Ljung R
    Haemophilia; 1999 Jul; 5(4):286-91. PubMed ID: 10950622
    [No Abstract]   [Full Text] [Related]  

  • 16. An overview of prion biology and the role of blood filtration in reducing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease.
    Cervia JS; Sowemimo-Coker SO; Ortolano GA; Wilkins K; Schaffer J; Wortham ST
    Transfus Med Rev; 2006 Jul; 20(3):190-206. PubMed ID: 16787827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New variant Creutzfeldt-Jakob disease: a controversial but potential blood transfusion risk.
    Basu A
    Nepal Med Coll J; 2003 Jun; 5(1):51-2. PubMed ID: 16583978
    [No Abstract]   [Full Text] [Related]  

  • 18. Is sporadic Creutzfeldt-Jakob disease transfusion-transmissible?
    Saá P
    Transfusion; 2020 Apr; 60(4):655-658. PubMed ID: 32246483
    [No Abstract]   [Full Text] [Related]  

  • 19. New-variant Creutzfeldt-Jakob disease and treatment of haemophilia. Executive Committee UK Haemophilia Directors' Organisation.
    Ludlam CA
    Lancet; 1998 Apr; 351(9111):1289-90. PubMed ID: 9643779
    [No Abstract]   [Full Text] [Related]  

  • 20. Surveillance for Creutzfeldt-Jakob disease among persons with hemophilia.
    Evatt B; Austin H; Barnhart E; Schonberger L; Sharer L; Jones R; DeArmond S
    Transfusion; 1998 Sep; 38(9):817-20. PubMed ID: 9738620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.